Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1989 5
1990 3
1991 2
1992 5
1993 2
1994 4
1995 4
1996 5
1997 2
1998 7
1999 7
2000 10
2001 12
2002 9
2003 13
2004 17
2005 18
2006 8
2007 10
2008 6
2009 12
2010 11
2011 12
2012 15
2013 15
2014 10
2015 13
2016 14
2017 22
2018 18
2019 13
2020 19
2021 18
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Results by year
Filters applied: . Clear all
Page 1
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
He A, Merkel B, Brown JWL, Zhovits Ryerson L, Kister I, Malpas CB, Sharmin S, Horakova D, Kubala Havrdova E, Spelman T, Izquierdo G, Eichau S, Trojano M, Lugaresi A, Hupperts R, Sola P, Ferraro D, Lycke J, Grand'Maison F, Prat A, Girard M, Duquette P, Larochelle C, Svenningsson A, Petersen T, Grammond P, Granella F, Van Pesch V, Bergamaschi R, McGuigan C, Coles A, Hillert J, Piehl F, Butzkueven H, Kalincik T; MSBase study group. He A, et al. Among authors: mcguigan c. Lancet Neurol. 2020 Apr;19(4):307-316. doi: 10.1016/S1474-4422(20)30067-3. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199096
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: mcguigan c. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
Interventions for preventing falls in people with multiple sclerosis.
Hayes S, Galvin R, Kennedy C, Finlayson M, McGuigan C, Walsh CD, Coote S. Hayes S, et al. Among authors: mcguigan c. Cochrane Database Syst Rev. 2019 Nov 28;11(11):CD012475. doi: 10.1002/14651858.CD012475.pub2. Cochrane Database Syst Rev. 2019. PMID: 31778221 Free PMC article.
Radiosynthesis of [18F]-Labelled Pro-Nucleotides (ProTides).
Cavaliere A, Probst KC, Paisey SJ, Marshall C, Dheere AKH, Aigbirhio F, McGuigan C, Westwell AD. Cavaliere A, et al. Among authors: mcguigan c. Molecules. 2020 Feb 6;25(3):704. doi: 10.3390/molecules25030704. Molecules. 2020. PMID: 32041321 Free PMC article.
Cognitive dysfunction in early multiple sclerosis: a review.
McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. McNicholas N, et al. Among authors: mcguigan c. QJM. 2018 Jun 1;111(6):359-364. doi: 10.1093/qjmed/hcx070. QJM. 2018. PMID: 28371862 Review.
Pediatric Parainfectious Encephalitis Associated With COVID-19.
Gaughan M, Connolly S, O'Riordan S, Tubridy N, McGuigan C, Kinsella JA. Gaughan M, et al. Among authors: mcguigan c. Neurology. 2021 Mar 16;96(11):541-544. doi: 10.1212/WNL.0000000000011476. Epub 2021 Jan 4. Neurology. 2021. PMID: 33397771 No abstract available.
Vaccine hesitancy among people with multiple sclerosis.
Yap SM, Al Hinai M, Gaughan M, Callanan I, Kearney H, Tubridy N, McGuigan C. Yap SM, et al. Among authors: mcguigan c. Mult Scler Relat Disord. 2021 Nov;56:103236. doi: 10.1016/j.msard.2021.103236. Epub 2021 Sep 2. Mult Scler Relat Disord. 2021. PMID: 34507240 Free PMC article.
Aryloxy phosphoramidate triesters as pro-tides.
Cahard D, McGuigan C, Balzarini J. Cahard D, et al. Among authors: mcguigan c. Mini Rev Med Chem. 2004 May;4(4):371-81. doi: 10.2174/1389557043403936. Mini Rev Med Chem. 2004. PMID: 15134540 Review.
311 results